Manager, Packaging Engineering
BeiGene
Summary
The Manager, Packaging Engineering NPI leads packaging engineering activities supporting new product development and commercialization from early-stage development through technical transfer and launch readiness.
Job description
Essential Functions of the Job
- Lead early stage commercial packaging development activities supporting New Product Introduction (NPI) partnering with Development/CMC colleagues to advance products through commercialization within established timelines and budgets.
- Represent the Global Commercial Supply Chain as the packaging engineering SME for early-stage development, partnering with CMC Development, Commercial Marketing, Regulatory, Quality, Planning, and Logistics.
- Partner with site-facing engineers to develop and execute qualification strategy, risk assessments, qualification plans, protocols, and summary report related to component qualification, packaging line testing, and temperature-controlled shipping systems.
- Develop and manage packaging documents (technical drawing, specification, technical assessment, development protocol and report) utilizing the Veeva system.
- Support commercial artwork development and approval through the artwork management system.
- Manage and execute change controls and deviations related to packaging.
- Support and execute organizational process improvement initiatives.
- Provide regulatory filing and submission support.
Supervisory Responsibilities
This position is currently an individual contributor role, with the potential for future people management responsibilities as the organization evolves.
Computer Skills
- Strong PC literacy required; MS Office skills (Outlook, Word, Excel, PowerPoint), MS Teams, Sharepoint.
- Experience in Veeva is beneficial but not required.
Other Qualifications
- Experience working in a global, complex supply chain organization preferred.
- An innovative mindset, with an ability to embrace change, respect differences of opinion, communicate openly and build consensus.
- Experience with large molecule, small molecule, and combination product packaging development and design controls.
- Experience with external service provider partnerships and relations.
- Skills to assess complex problems relating to materials and processes, recommending and implementing solutions.
- Solid understanding of comprehensive global pharmaceutical regulatory requirements (e.g. FDA, EMEA, cGMP, GDP, and GCP).
- Flexibility to adapt and multi-task effectively to manage multiple ongoing projects with shifting priorities.
Travel
Up to 25%
Requirements
- Strong PC literacy required; MS Office skills (Outlook, Word, Excel, PowerPoint), MS Teams, Sharepoint
- Experience with large molecule, small molecule, and combination product packaging development and design controls
- Experience with external service provider partnerships and relations
- Skills to assess complex problems relating to materials and processes, recommending and implementing solutions
- Solid understanding of comprehensive global pharmaceutical regulatory requirements (e.g. FDA, EMEA, cGMP, GDP, and GCP)
- Flexibility to adapt and multi-task effectively to manage multiple ongoing projects with shifting priorities
- Experience working in a global, complex supply chain organization preferred
- Experience in Veeva is beneficial but not required
Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness Benefits
- Annual Bonus Plan
- Equity Awards
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.